Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.620 | strong | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.430 | strong | 0.750 | 0 | 0 | 2015 | 2019 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
group | 0.410 | strong | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 |